Lazard Asset Management
RXST icon

Lazard Asset Management’s RxSight RXST Stock Holding History

Lazard Asset Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,160
Closed -$158K – 2245
2025
Q2 		$158K Sell
12,160
-217,109
-95% -$3.26M ﹤0.01% 1757
2025
Q1 		$5.79M Sell
229,269
-34,170
-13% -$1.02M 0.01% 639
2024
Q4 		$9.06M Buy
263,439
+160,598
+156% +$7.24M 0.01% 488
2024
Q3 		$5.08M Buy
102,841
+89,434
+667% +$4.58M 0.01% 625
2024
Q2 		$806K Buy
13,407
+7,083
+112% +$405K ﹤0.01% 1032
2024
Q1 		$326K Sell
6,324
-280
-4% -$13.7K ﹤0.01% 1162
2023
Q4 		$266K Buy
6,604
+3,376
+105% +$99K ﹤0.01% 1299
2023
Q3 		$90K Buy
3,228
+781
+32% +$23.3K ﹤0.01% 1672
2023
Q2 		$70K Buy
+2,447
New +$54.4K ﹤0.01% 1718

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management's RXST Position: Q3 2025 in Review

Lazard Asset Management sold out of RxSight (RXST) in Q3 2025, closing a stake of 12,160 shares — an estimated $158K sold.

Lazard Asset Management first reported a position in RXST in Q2 2023 and held it in 9 quarters. The position peaked at $9.06M in Q4 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Lazard Asset Management reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 12,160 RxSight shares in Q3 2025, an estimated $158K.
  • Lazard Asset Management first reported a position in RxSight in Q2 2023 and held it in 9 quarters.
  • Lazard Asset Management's RxSight position peaked at $9.06M in Q4 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.